1. The selective dopamine D₂ receptor antagonist raclopride discriminates between dopamine-mediated motor functions

   • Sven Ove Ögren
   • H»kan Hall
   • Sven-Erik Sjöstrand

   Original Investigations Pages: 287 - 294

2. Pharmacokinetics of the antidepressant drug viloxazine in normal subjects and in epileptic patients receiving chronic anticonvulsant treatment

   • F. Pisani
   • A. Fazio
   • E. Perucca

   Original Investigations Pages: 295 - 298

3. Calcium agonists and antagonists of the dihydropyridine type: Antinociceptive effects, interference with opiate-μ-receptor agonists and neuropharmacological actions in rodents

   • F. Hoffmeister
   • D. Tettenborn

   Original Investigations Pages: 299 - 307

4. Behavioral and physiological effects associated with changes in muscarinic receptors following administration of an irreversible cholinergic agonist (BM 123)

   • Roger W. Russell
   • Cheryll A. Smith
   • Jerene J. Waite

   Original Investigations Pages: 308 - 315

5. HPLC with electrochemical detection to measure chlorpromazine, thioridazine and metabolites in human brain

   • Clive N. Svendsen
   • Edward D. Bird

   Original Investigations Pages: 316 - 321

6. Inhibition of the shake response in rats by adenosine and 2-chloroadenosine

   • S. Y. H. Tse
   • E. T. Wei

   Original Investigations Pages: 322 - 326

7. Conditional hyperthermia in response to atropine associated with a hypothermic drug

   • Harald K. Taukulis

   Original Investigations Pages: 327 - 331

8. Interaction of carbamazepine and other drugs with adenosine (A₁ and A₂) receptors

   • Y. Fujiwara
   • M. Sato
   • S. Otsuki

   Original Investigations Pages: 332 - 335

9. Effects of adrenaline on the acquisition and maintenance of ethanol preference in a taste conditioning paradigm

   • Carmen Guaza
   • Sara Borrell
   • Jose Borrell

   Original Investigations Pages: 336 - 340

10. Drug discrimination procedures: Differential characteristics of the drug A vs drug B and the drug A vs drug B vs no drug cases

    • Michael D. B. Swedberg
    • Torbjörn U. C. Järbe

    Original Investigations Pages: 341 - 346

11. New approaches to postmarketing surveillance

    • Seymour Fisher
    • Stephen G. Bryant
    • Ronica M. Kluge

    Original Investigations Pages: 347 - 350

12. Changes in noradrenaline plasma levels and behavioural responses induced by benzodiazepine agonists with the benzodiazepine antagonist Ro 15-1788

    • T. Duka
    • M. Ackenheil
    • R. Dorow

    Original Investigations Pages: 351 - 357

13. Dopamine agonist-induced stereotypic grooming and self-mutilation following striatal dopamine depletion

    • Stanley L. Hartgraves
    • Patrick K. Randall

    Original Investigations Pages: 358 - 363

14. Effects of physostigmine on memory test performance in normal volunteers

    • C. M. Smith
    • J. S. Coogan
    • S. Hart

    Original Investigations Pages: 364 - 366

15. The effect of midazolam and β-carboline carboxylic acid ethyl ester on behaviour, steroid hormones and central monoamine metabolites in social groups of talapoin monkeys

    • S. V. Vellucci
    • J. Herbert
    • E. B. Keverne

    Original Investigations Pages: 367 - 372

16. The cardiovascular effects of nicotine during stress

    • Kenneth A. Perkins
    • Leonard H. Epstein
    • Richard Stiller

    Original Investigations Pages: 373 - 378

17. Modification of visual orientation illusions by drugs which influence dopamine and GABA neurones: Differential effects on simultaneous and successive illusions

    • M. H. Gelbtuch
    • J. E. Calvert
    • O. T. Phillipson

    Original Investigations Pages: 379 - 383

18. Platelets and biogenic amines. 2. Indications for a discrete low affinity uptake mechanism shared by norepinephrine and 5-hydroxytryptamine in human platelets

    • R. Malmgren

    Original Investigations Pages: 384 - 389

19. 6-Hydroxydopamine lesions of the nucleus accumbens, but not of the caudate nucleus, attenuate enhanced responding with reward-related stimuli produced by intra-accumbens d-amphetamine

    • Jane R. Taylor
    • Trevor W. Robbins

    Original Investigations Pages: 390 - 397

20. The effect of lithium on 5-HT-mediated neuroendocrine responses and platelet 5-HT receptors

    • P. W. Glue
    • P. J. Cowen
    • D. G. Grahame-Smith

    Original Investigations Pages: 398 - 402

21. Suppression of the hypo- and hyperthermic responses to 5-HT agonists following the repeated administration of monoamine oxidase inhibitors

    • Gary A. Gudelsky
    • James I. Koenig
    • Herbert Y. Meltzer

    Original Investigations Pages: 403 - 407

22. Potentiation of disruptive effects of dextromethorphan by naloxone on fixed-interval performance in rats

    • Tambay Taşkin

    Original Investigations Pages: 408 - 411

23. Serum concentrations and clinical effect of zuclopenthixol in acutely disturbed, psychotic patients treated with zuclopenthixol acetate in Viscoleo^®

    • A. Amdisen
    • T. Aaes-Jørgensen
    • M. S. Nielsen

    Original Investigations Pages: 412 - 416

24. Zuclopenthixol levels in serum and breast milk

    • Tove Aaes-Jørgensen
    • Flemming Bjørndal
    • Ulla Bartels

    Original Investigations Pages: 417 - 418

25. Behavioral effects of adenosine analogs in squirrel monkeys: relation to adenosine A₂ receptors

    • R. D. Spealman
    • V. L. Coffin

    Rapid Communication Pages: 419 - 421

26. Why do some antidepressants promote suicide?

    • T. J. Feuerstein
    • R. Jackisch

    Letter to the Editors Pages: 422 - 422